Seneca Growth Capital Vct Dividends - HYG

Seneca Growth Capital Vct Dividends - HYG

Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Seneca Growth Capital Vct Plc HYG London Ordinary Share GB0031256109 ORD 1P
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  0.00 0.0% 22.00 22.00 22.00 22.00 22.00 01:00:00
more quote information »
Industry Sector
EQUITY INVESTMENT INSTRUMENTS

Seneca Growth Capital Vct HYG Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
28/12/2018InterimGBX1031/12/201731/12/201810/01/201911/01/201925/01/201910
14/08/2013InterimGBX330/12/201230/06/201325/09/201327/09/201325/10/20133
08/04/2011FinalGBX531/12/200931/12/201025/05/201127/05/201101/07/20115
31/03/2010FinalGBX531/12/200831/12/200902/06/201004/06/201002/07/20105
27/02/2004FinalGBX0.531/12/200231/12/200331/03/200402/04/200407/05/20040.5
24/03/2003FinalGBX0.7531/12/200131/12/200202/04/200304/04/200306/05/20030.75

Top Dividend Posts

DateSubject
09/1/2019
12:47
rivaldo: Of course the price will either multi-bag if SCLP does well or will fall if not. But I'm also confident that ODX will do well over time. And there's also a large investment in OR Productivity, plus Arecor seems to be doing pretty well. Plus HYG now have a large cash pile to support the share price and to invest in new ventures or support existing investments.
01/9/2016
12:40
rivaldo: Interims out - NAV down to 69.1p due to the decline in SCLP's share price. SCLP is up some 10% since 30/6, so I would expect NAV to be up nearer say 71p now: Http://www.investegate.co.uk/hygea-vct-plc--hyg-/gnw/hygea-vct-plc---half-yearly-report/20160831070031H8373/ Hallmarq is still progressing very well. It's surely just a matter of time before it IPO's on AIM, at which point I'd expect NAV serious upside. I'm also hopeful for the £450k carrying value in AIM-quoted ODX - this could be worth a lot more in a few months' time with decent news flow.
10/6/2014
09:13
timbo003: Tristel worth keeping an eye on. Up around 20% today following a trading update and now up around 65% this year, they accounted for 0.6p/share of Hygea's NAV at year end, so that should be more like 1p/share now. http://uk.advfn.com/exchanges/LSE/tristel-TSTL/share-price?java=1
01/4/2014
14:17
rivaldo: Results just out: Http://www.investegate.co.uk/hygea-vct-plc--hyg-/gnw/hygea-vct-plc---annual-financial-report-and-agm/20140401134723H3425/ 97p NAV now, so the share price is at a substantial discount. SCLP will either be a massive winner or a total flop I suppose. But Hallmarq looks better and better imo. It made £648k PBT to 31/8/13 at a pretty reasonable £10m valuation - and that's before any contribution from the now-launched Petvet, which has a massive global market. I wish I could buy shares directly in Hallmarq. And Eykona suddenly looks like being a bit of a goer since it's suddenly been discovered at the heart of the 3D printing industry: "Eykona became aware of the opportunity within the 3D printing market to develop its camera as the world's first high resolution 3D scanner for the consumer market." If progress in the USA continues, who knows what it might become worth?
25/2/2014
08:44
rivaldo: ODX has roughly doubled over the last few weeks. At 30/6/13 HYG's holding was worth £437k, so this must now be worth around £850k or so - quite a significant increase in the context of HYG's £5.4m m/cap. EKF is also rising nicely, to 38p now and a £475k worth to HYG. HYG is developing nicely, with SCLP, Hallmarq, ODX and EKF providing a variety of supports for the share price and NAV.
20/1/2014
07:24
timbo003: Today's RNS from EKF sounds more than just interesting. http://www.investegate.co.uk/ekf-diagnostics-hldg--ekf-/rns/pointman-enriches-low-level-mutations-from-blood/201401200700170025Y/ At the last full valuation (June 30th), EKF accounted for 4p/share of Hygea's NAV (with the underlying share price for EKF at around 26p/share), at close on Friday, EKF were around 35p/share, so presumably they currently account for around 5.5p/share of Hygea's NAV. I suspect EKF will have an "up" day today. Here's the link to their summary quote page: http://uk.advfn.com/p.php?pid=quote&symbol=L%5eEKF
09/12/2013
08:35
rivaldo: Terrific RNS from SCLP today, with a subsequent share price jump to 40p now: Http://www.investegate.co.uk/scancell-hlds--sclp-/rns/new-data-for-scib1-in-metastatic-melanoma/201312090700129752U/
03/10/2013
19:11
timbo003: It was at the Scancell Investor day on Tuesday, there are a number of write ups of the event on the LSE Scancell BB, my own version of events is on the ADVFN Scancell thread After the meeting I had a chance to chat to a few people, including: a couple of ADVFNers, Lucius (chief cheese fund manager for the Oxford VCTs), James (Chairman and fund manager at Hygea VCT) and Chris (market maker at Panmure). The Oxford VCTs took up their allocation in the open offer, Hygea did not (for technical reasons), both Lucius and James seemed impressed with the Scancell BOD and with progress. I do not think they will be selling. Note also that the Hygea share price (which usually tracks the Scancell share price) did not follow Scancell down yesterday, which I suspect was after all the praise that James was showering on Hallmarq (in reponse to a question from me). He was incredibly bullish on Hallmarq, but he says the problem is assigning a value, none of the current PE valuations are really appropriate.
06/8/2013
15:14
rivaldo: Chrres sbp - imagine what any news from Arecor re a universal flu vaccine might do to HYG's share price :o)) Excuse me whilst I have a short daydream... I note that SCLP is up another 3.5p or so to 38.75p, making HYG's NAV around 106p-107p.
20/5/2013
22:42
rivaldo: Timbo, I hope you don't mind me copying here your poat from T.M.F re HYG as it's a useful prompter - though I think Freehand is actually now the second biggest investment, with EKF perhaps third (as an aside, personally I can't see much upside for EKF at the current high valuation for some time to come) : http://boards.fool.co.uk/there-is-a-useful-agm-report-for-ekf-diagnostics-12810965.aspx "There is a useful AGM report for EKF Diagnostics over on the Sharesoc forum (you need to register to read, but its free): http://sharesoc.ning.com/forum/topics/the-agm-forum?commentI... EKF are the second largest Aim quoted investmment in the Hygea portfolio, summary details are here http://www.investegate.co.uk/CompData.aspx?EKF EKF was on Hygea's books at £354K at 31st December and the share price is now more or less where it was at the end of the year (30p), so it contributes around 3.5p/share of Hygea's NAV (adjusted for management incentive). Interesting to read that there were two approaches for EKF last year, one of which was "serious" from a large international player and the possible reasons why it did not proceed. Perhaps it's only a matter of time before EKF get taken out. Should this occur, it would represent a significant liquidy event and profit for Hygea (they bought their stake for £260K)."
Your Recent History
LSE
HYG
Seneca Gro..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191020 16:41:08